Agios Pharmaceuticals (8AP.F) Q4 2025 Earnings

30OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.69
-1.58
-1.48
-1.37

Details

Expected EPS
-1.6393415152
Actual EPS
-1.538632
Surprise EPS
0.1
Surprise Percent
+6.14%

Description

Agios Pharmaceuticals (8AP.F) has reported earnings of -1.538632 per share for Q4 2025.

0 Comments

Share your thoughts